The 2023 Entrepreneur & Investor Life Sciences Summit attracted local and national investors who a lot to say about the state of venture capital in the life sciences industry. A panel, focused on financing beyond venture capital, included MODERATOR: Nola Masterson with Science Futures Management, and PANELISTS: Chris McFadden with KKR, Geoffrey Loos with CapM Advisors, and Chris Mayo with the London Stock Exchange Group. Tune in to see what they had to say.

Chris Gill, President and CEO of SVASE interviews Nola Masterson, Mangaging Director of Science Futures.

Chapters: (Advance the marker) 0:59 A career with many "firsts" 5:00 Some very creative financing models in the early days 9:11 Going for the "big one" and the founding of Sequenom 17:08 What excites you about the industry today? 20:10 Bioethics and the Dalai Lama 23:47 The open science conflict 26:16 Bullish about the IT industry bringing biotech into the 21st Century 28:25 A childhood dream come true Today's show will give you some of everything. Our guest is Nola Masterson. She was the first biotech analyst on Wall Street, she's a founder of Sequenom, and she blazed trails in venture capital. Ever on the front lines, she reminisces about earlier times, but also weighs in on issues of today. What perspective has her career given her on bioethics? What does she think of the strong movement toward "open science." Never at a loss, Nola Masterson has been called "the guru of biotech."

Collaborative investors, fueling companies together, is how we create change.